SKIN — Beauty Health Co Share Price
- $124.03m
- $306.17m
- $334.29m
- 78
- 62
- 40
- 62
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.39 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 13.28 | ||
Price to Sales | 0.37 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -5.57% | ||
Return on Equity | -52.34% | ||
Operating Margin | -10.28% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 119.09 | 260.09 | 365.88 | 397.99 | 334.29 | 288.46 | 309.18 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
The Beauty Health Company is a medical technology meets beauty company that delivers skin-health experiences. The Company and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. It specializes in skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus, and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in nanoneedling and microneedling, where its products are designed to provide either a non-invasive (nanoneedling) or minimally invasive (microneedling) skin treatment to individuals. Keravive specializes in scalp health with its products that are designed to support the hair’s natural growth by cleansing, exfoliating, and hydrating the scalp and hair follicles.
Directors
- Brenton Saunders CHM (51)
- Andrew Stanleick PRE
- Liyuan Woo CFO (49)
- Kellie Sears CHO
- Daniel Watson EVP
- Michael Capellas IND (67)
- Julius Few IND (53)
- Desiree Gruber IND (54)
- Michelle Kerrick IND (58)
- Brian Miller IND (46)
- Doug Schillinger IND (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 8th, 2020
- Public Since
- February 10th, 2020
- No. of Shareholders
- 42
- No. of Employees
- 769
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 125,245,176

- Address
- 2165 Spring Street, LONG BEACH, 90806
- Web
- https://investors.beautyhealth.com/
- Phone
- +1 9083044504
- Auditors
- Deloitte & Touche LLP
Upcoming Events for SKIN
Q2 2025 Beauty Health Co Earnings Release
Similar to SKIN
Caring Brands
NASDAQ Capital Market
China Liberal Education Holdings
NASDAQ Capital Market
Color Star Technology Co
NASDAQ Capital Market
E-Home Household Service Holdings
NASDAQ Capital Market
EpicQuest Education International
NASDAQ Capital Market
FAQ
As of Today at 19:32 UTC, shares in Beauty Health Co are trading at $0.99. This share price information is delayed by 15 minutes.
Shares in Beauty Health Co last closed at $0.99 and the price had moved by -67.64% over the past 365 days. In terms of relative price strength the Beauty Health Co share price has underperformed the S&P500 Index by -70.13% over the past year.
The overall consensus recommendation for Beauty Health Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBeauty Health Co does not currently pay a dividend.
Beauty Health Co does not currently pay a dividend.
Beauty Health Co does not currently pay a dividend.
To buy shares in Beauty Health Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.99, shares in Beauty Health Co had a market capitalisation of $124.03m.
Here are the trading details for Beauty Health Co:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SKIN
Based on an overall assessment of its quality, value and momentum Beauty Health Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Beauty Health Co is $1.57. That is 58.54% above the last closing price of $0.99.
Analysts covering Beauty Health Co currently have a consensus Earnings Per Share (EPS) forecast of -$0.27 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Beauty Health Co. Over the past six months, its share price has underperformed the S&P500 Index by -36.74%.
As of the last closing price of $0.99, shares in Beauty Health Co were trading -34.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Beauty Health Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Beauty Health Co's management team is headed by:
- Brenton Saunders - CHM
- Andrew Stanleick - PRE
- Liyuan Woo - CFO
- Kellie Sears - CHO
- Daniel Watson - EVP
- Michael Capellas - IND
- Julius Few - IND
- Desiree Gruber - IND
- Michelle Kerrick - IND
- Brian Miller - IND
- Doug Schillinger - IND